Skip to main content
logo
Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
2.300
+0.010 (0.44%)
At close: Feb 4, 2026, 4:00 PM EST
2.217
-0.083 (-3.59%)
Pre-market: Feb 5, 2026, 8:00 AM EST

Prelude Therapeutics Revenue

Prelude Therapeutics had revenue of $6.50M in the quarter ending September 30, 2025, with 116.67% growth. This brings the company's revenue in the last twelve months to $10.50M, up 250.00% year-over-year. In the year 2024, Prelude Therapeutics had annual revenue of $7.00M.

Revenue (ttm)
$10.50M
Revenue Growth
+250.00%
P/S Ratio
16.65
Revenue / Employee
$80,153
Employees
131
Market Cap
189.51M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.00M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Editas Medicine46.38M
C4 Therapeutics30.11M
Sol-Gel Technologies18.97M
Ovid Therapeutics6.61M
Camp4 Therapeutics3.80M
Humacyte1.57M
NeOnc Technologies Holdings59.99K
Revenue Rankings

PRLD News

More News